Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07126327

Peristeen Light Explorative Clinical Investigation

The goal of this exploratory clinical investigation is to understand the clinical benefits of Peristeen Light in adult patients with faecal incontinence, chronic constipation and/or time-consuming bowel management procedures.

The primary objective is to evaluate changes in bowel-function when using Peristeen Light. Participants will use Peristeen Light for 12 weeks test period.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Århus University Hospital, Aarhus, Gotland, Denmark

Loading trial locations.

About this study

The goal of this exploratory clinical investigation is to understand the clinical benefits of Peristeen Light in adult patients with faecal incontinence, chronic constipation and/or time-consuming bowel management procedures.

The primary endpoint is bowel function measured on a 10 cm Visual Analog Scale (VAS) at Baseline Visit and end of Clinical Investigation visit.

Participants will use Peristeen Light for 12 weeks test period.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Has given written informed consent
  • Is at least 18 years old
  • Has full legal capacity
  • Is able (assessed by investigator) and willing to adhere to clinical investigational procedures during clinical investigation-al duration
  • Has access to and is able to use a smartphone
  • Has constipation and/or faecal incontinence based on one or more of the following symptoms during the last 3 month: Straining in more than 25% of defecations, lumpy stools (Bristol Stool Type 1 and 2) in more than 25% of defecations, sensation of incomplete evacuation in more than 25% of defecations, sensation of anorectal obstruction/blockage in more than 25% of defecations, need to use manual maneuvers to facilitate defecation in more than 25% of defecations, fewer than three spontaneous bowel movements per week, loose stools are rarely present without use of laxatives, recurrent uncontrolled passage of faecal material (other words to describe this could be: Soiling, leak-age, passive faecal incontinence of flatus, mucus and/or stool)
  • Is assessed (by investigator) to have a need for low-volume TAI minimum every other day

Exclusion criteria

  • Is participating in any other clinical investigation during this investigation
  • Has previously completed this investigation
  • Is former or current user of transanal irrigation (low- and high volume)
  • Has known hypersensitivity towards the device used in the investigation
  • Is pregnant
  • Has known anal stenosis
  • Has active/recurrent colorectal cancer
  • Has had anastomotic colorectal surgery within the last 3 months
  • Has ischaemic colitis
  • Has active inflammatory bowel disease
  • Has acute diverticulitis or diverticular abscess
  • Has medicine induced constipation (e.g. due to opioids)
  • Has chronic diarrhea
  • Has bowel dysfunction due to neurogenic disorder(s)
  • Is in need of high-volume TAI (as estimated by investigator)

Treatment and study plan

Peristeen Light - trans anal irrigation system

Device

Subjects naive to TAI will use Peristeen Light trans anal irrigation

Primary outcomes

  1. Bowel function measured on a 10 cm Visual Analog Scale (VAS) at Baseline Visit (V1) and End of Clinical Investigation Visit (V7).

    Time frame: From enrollment to the end of treatment at week 12.

    0 cm = worst possible bowel function and 10 cm = best possible bowel function.

Study contacts

Contact information is provided by the study sponsor or research team.

Michel Briand de Crevecoeur

CONTACT

[email protected]

+4549111272

Sponsors and collaborators

Lead sponsor

Coloplast A/S

Industry

Registry information

Official study title

An Explorative Clinical Investigation to Understand the Clinical Benefits of Peristeen Light

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 17, 2025
Registry last updated
Apr 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.